AAV5-miHTT (AMT-130) gene therapy for Huntington's disease: A review of mechanisms and phase I/II clinical trial evidence

Gene Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles